刘晓惠： 高血压药物联合治疗　.pptVIP

* There is evidence that multiple-mechanism agents are a highly effective and well-tolerated therapeutic strategy for managing patients with hypertension. Numerous agents offering a dual mode of action are already available for the treatment of hypertension, such as agents combining renin angiotensin system blockade with a diuretic (e.g. valsartan plus hydrochlorothiazide [Co-Diovan]) or agents combining angiotensin-converting enzyme inhibition with calcium channel blockade (e.g. benazepril plus amlodipine [Lotrel]).1 A notable absentee, until recently, from current multiple-mechanism therap